HD-OPM Archive
Topics › Risk assessment & lab tests

Retinal AI imaging may predict CVD risk; in CLAiR, ~1 in 4 met lipid-lowering criteria

Louis Nervegna · Apr 10, 2026 · ♥ 20 reactions · 9 comments · original Facebook post
Risk assessment & lab testsAI & digital tools
AI summary & key facts

Louis highlights that cheap, quick eye imaging analyzed by AI could estimate cardiovascular risk. In the CLAiR randomized trial, almost a quarter of patients without heart disease met guideline thresholds for lipid lowering based on a 7.5% 10-year ASCVD risk target.

More and more research is hinting that retinal imaging can predict risk for CVD.

The health of the vasculature in your eyes gives a window into the health of your overall vasculature.

The advantage of this test is that it is cheap, fast, and non-invasive. It is already performed by many optometrists during a standard eye exam. It only takes a few seconds to image each eye.

The AI tools necessary to analyze the images and determine CVD risk are still in the research stage. But it may not be very long before this technology becomes available.

What fascinates me is the idea that it could one day be used to non-invasively track progression. Imagine getting this test every month to put together an AI-generated picture of how your disease is progressing (or regressing!). You could see how various interventions that you are trying (diet, exercise, medication, supplements) are affecting your disease in real time.

#retinalimagingHD #retinaHD

Research cited

Shared from Medscape · original post

Almost one fourth of patients with no history of heart disease met the clinical guidelines for starting lipid-lowering therapy, according to a new prospective, multicenter randomized trial of an AI algorithm that analyzes retinal images to estimate cardiovascular risk.

The CLAiR AI trial used an investigative AI algorithm trained against the 10-year atherosclerotic cardiovascular disease (ASCVD) risk score of 7.5%, derived from the Pooled Cohort Equations introduced in the American College of Cardiology (ACC) and American Heart Association (AHA) 2013 cholesterol guidelines. Should Your Patient Be on Statins? Maybe the Eyes Can Tell (Medscape)

No photo description available.
← newer: Vitamin C pharmacokinetics: Levine's PNAS study shows absorpolder: Fact check: TG/HDL under 1 does not nullify statin or LDL/Ap →